B. J. Kennedy, M.D., F.A.C.P.
Kennedy BJ. Adrenocortical Hyperfunction in Cancer.. Ann Intern Med. 1961;54:1045. doi: 10.7326/0003-4819-54-5-1045_2
Download citation file:
Published: Ann Intern Med. 1961;54(5):1045.
This content is PDF only. Please click on the PDF icon to access.
Adrenocortical hyperfunction has occurred in association with carcinomas not originating in the adrenal glands. These cancers included those from the bronchus, thymus, pancreas, and prostate. The syndrome has been characterized by an acute onset, occurrence in young adults, and a short duration of life. The fulminating course appears to be due to the adrenal cortical overactivity.
Three patients have been studied: (1) a 23-year-old female with a small-cell carcinoma of the thyroid with extensive metastases, bilateral pheochromecytoma, and hyperplasia of the adrenal cortex; (2) a 33-year-old male with Hodgkin's disease and adrenal hyperfunction; and (3) a 57-year-old male with metastatic
Learn more about subscription options.
Register Now for a free account.
Adrenal Disorders, Endocrine and Metabolism, Hematology/Oncology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only